Literature DB >> 10981872

Immunohistochemistry in the differential diagnosis of acinar and endocrine pancreatic neoplasms.

M Skacel1, A H Ormsby, R E Petras, J T McMahon, W H Henricks.   

Abstract

Histologic differential diagnosis of acinar cell carcinoma (ACC), mixed acinar-endocrine cell carcinoma (MAEC), and pancreatic endocrine tumors (PET) can be difficult but is important because of differences in their clinical behavior. This study investigates the utility of immunohistochemistry (IHC) in this differential diagnosis using immunohistochemical stains that are available in most laboratories. IHC was performed on paraffin-embedded tissue in ACC (n = 6), MAEC (n = 2), and PET (n = 13), using synaptophysin (SYN), chromogranin (CHR), chymotrypsin (CHY), and alpha-1-antitrypsin (AAT). Electron microscopy (EM) was performed in all cases to confirm the diagnosis. Long-term follow-up and death of disease (DOD) was known in all patients. The ACCs stained as follows: CHY (4/6), AAT (3/6), SYN (4/6); CHR was negative in all cases. Both cases of MAEC stained with CHY, AAT, and SYN (2/2); CHR was negative. PET stained as follows: SYN (13/13), CHR (8/13), CHY (4/13), AAT (5/13). In the ACC/ MAEC group, six of eight patients were DOD at mean follow-up of 11 months. Among the PET, two of 16 patients were DOD at mean follow-up of 37 months. Considerable immunophenotypic overlap exists between ACC, MAEC, and PET. Consequently, one can neither confirm nor rule out a diagnosis of ACC or MAEC using generally available immunohistochemical stains alone. These findings support a role for EM in the evaluation of exocrine and endocrine pancreatic neoplasms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981872     DOI: 10.1097/00129039-200009000-00006

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  7 in total

1.  Mixed neuroendocrine non-neuroendocrine neoplasm: a case report and review.

Authors:  Sawako Hiroi; Rie Yamamoto; Michinori Hamaoka; Masakata Hoshino; Tamito Sasaki; Yasuhiro Matsugu; Takashi Nishisaka; Hideki Nakahara; Toshiyuki Itamoto
Journal:  Clin J Gastroenterol       Date:  2021-11-18

2.  Primary acinar cell carcinoma of the liver.

Authors:  Valérie Hervieu; Catherine Lombard-Bohas; Jérôme Dumortier; Olivier Boillot; Jean-Yves Scoazec
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

3.  Mixed acinar-endocrine carcinoma of pancreas: A case report and brief review of the literature.

Authors:  Zhenzhen Liu; Chengyong Dong; Chengye Wang; Qinlong Liu; Deguang Sun; Liming Wang
Journal:  Onco Targets Ther       Date:  2015-07-03       Impact factor: 4.147

4.  Metastatic mixed acinar-endocrine carcinoma of the pancreas treated with a multidisciplinary approach: a case report.

Authors:  Takeo Hara; Yoshiyuki Fujiwara; Hidenori Takahashi; Keijiro Sugimura; Jeong-Ho Moon; Takeshi Omori; Norikatsu Miyoshi; Akira Tomokuni; Hirofumi Akita; Shogo Kobayashi; Masayoshi Yasui; Hiroshi Miyata; Masayuki Ohue; Masato Sakon; Yasuhiko Tomita; Masahiko Yano
Journal:  Surg Case Rep       Date:  2017-03-30

5.  Detection of Chymotrypsin by Optical and Acoustic Methods.

Authors:  Ivan Piovarci; Tibor Hianik; Ilia N Ivanov
Journal:  Biosensors (Basel)       Date:  2021-02-26

Review 6.  2021 Update on Diagnostic Markers and Translocation in Salivary Gland Tumors.

Authors:  Malin Tordis Meyer; Christoph Watermann; Thomas Dreyer; Süleyman Ergün; Srikanth Karnati
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

7.  EUS-guided FNA in Diagnosing Pancreatic Lesions: Strength and Cytological Spectrum.

Authors:  Neha Nigam; Archana Rastogi; Vikram Bhatia; Binit Sureka; Priyanka Jain; Chhagan Bihari
Journal:  J Cytol       Date:  2019-09-20       Impact factor: 1.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.